Forecast & Rating13 analysts currently cover MiniMed, with about 84.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $20.83, about 0.6% upside from the current price of $20.70. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study MiniMed closely still see room for the stock to rise. Data as of Aug 11, 2026; for reference only and not investment advice.
Aug 11, 2026Price forecast
$20.830.64%
Forecast & RatingStrong buy
13analysts
- Strong buy76.92%
- Buy7.69%
- Hold7.69%
- Sell0.00%
- Strong sell7.69%
Target price forecast
Forecast baselineAug 11, 2026
Forecast met0.0%
Stock price$20.70
Average forecast price$20.8
Highest forecast price$25
Lowest forecast price$15
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.